HAW: Neurological Stereotaxic Instrument

Product code HAW, “Neurological Stereotaxic Instrument” in FDA's classification database, is a Class II device type under 21 CFR 882.4560 (stereotaxic instrument), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 426 clearances under HAW, 118 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
HAW
Regulation
21 CFR 882.4560
Class
II
Panel
Neurology
Clearances
426
Most recent
Oct 15, 2026
Median review, last 2 years
162 days
Third-party review
Not eligible
Implant
No

What it covers

A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.

The identification in 21 CFR 882.4560, stereotaxic instrument. FDA gives HAW no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K262214Disposable Reflective Marker Spheres (AM-BK115S, AM-BL130S)Guangzhou Aimooe Technology Co., Ltd.Oct 15, 2026Traditional
K253856Geniant Cranial (Navigated Neurosurgical Positioning Robot)Koh Young Technology, Inc.Sep 10, 2026Traditional
K261932Leksell® Vantage Stereotactic SystemElekta Solutions ABAug 5, 2026Traditional
K253663Zeta Navigation SystemZeta Surgical, Inc.May 1, 2026Traditional
K253379Stealth AXiS Cranial clinical applicationMedtronic Navigation, Inc.Mar 26, 2026Traditional
K231897NeuroAlign softwareMedivis, Inc.Oct 21, 2025Traditional
K251317SOLOPASS 2.0 SystemIntravent Medical PartnersSep 5, 2025Traditional
K250893Ball Joint Guide Array (66295)Bayer Medical Care, Inc.Sep 4, 2025Traditional
K250505EZ-FIDUCIALSPhasor Health, LLCJul 9, 2025Traditional
K242575Stereotaxic Guiding Surgical Devices, NaoTrac SBrain Navi Biotechnology Co., Ltd.May 23, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 426 with a free account)

Clearances by year

118 HAW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)5162
20259163
20247107
202314142
20227128
20219168
2020588
201910147
20186112
20177226
20169175
201510232
20145238
20133172
20128178
2011466

Who submits

57 applicants cleared a HAW device since 2011. 50% of the clearances went to applicants in United States, then Germany (20%), Canada (8%) and France (8%). By type: Traditional 83%, Special 16% and Abbreviated 1%.

ApplicantClearances since 2011
Medtronic Navigation, Inc.15
Brainlab AG12
ClearPoint Neuro, Inc.10
Medtech S.A4
Mri Interventions, Inc.4
Synaptive Medical, Inc.4
7D Surgical, Inc.3
Elekta Instrument AB3

How FDA classifies it

Class II (performance standards).

From 21 CFR 882.4560.

Standards

21 CFR 882.4560 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent HAW clearances declared.

Ask about HAW

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about HAW

What is FDA product code HAW?

Product code HAW, “Neurological Stereotaxic Instrument” in FDA's classification database, is a Class II device type under 21 CFR 882.4560 (stereotaxic instrument), reviewed by FDA's Neurology panel. FDA's 510(k) database lists 426 clearances under HAW, 118 of them since 2011.

How many 510(k) clearances are there under HAW?

FDA’s 510(k) database listed 426 clearances under HAW as of Oct 29, 2026, 118 of them decided since 2011; the most recent decision was Oct 15, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a HAW 510(k)?

For the 15 HAW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 162 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most HAW clearances?

Since 2011: Medtronic Navigation, Inc. (15), Brainlab AG (12), ClearPoint Neuro, Inc. (10), Medtech S.A (4) and Mri Interventions, Inc. (4). 57 applicants have cleared a HAW device in that time.

Sources

  1. FDA product classification: HAW · Product Classification database
  2. 21 CFR 882.4560: Stereotaxic instrument · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for HAW · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow HAWGet an email when FDA clears, recalls or publishes guidance for HAW devices.

Know what FDA already cleared.